Omega-3 fatty acids for autistic spectrum disorder: A systematic review

Journal of Autism and Developmental Disorders

Volumn 39, Issue 8, 2009, Pages 1145-1154

  Bent, Stephen ^a   Bertoglio, Kiah ^b   Hendren, Robert L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Complementary and alternative medicine; Omega 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANXIETY; ARTICLE; ASPERGER SYNDROME; AUTISM; BEHAVIOR; BEHAVIOR DISORDER; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; FEVER; GASTROINTESTINAL SYMPTOM; HEALTH; HUMAN; HYPERACTIVITY; LANGUAGE; LEARNING; MEDLINE; PARENT; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; SKILL; STEREOTYPY; SYSTEMATIC REVIEW;

AUTISTIC DISORDER; CHILD; COMPLEMENTARY THERAPIES; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 70349608578     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-009-0724-5     Document Type: Article

References (25)

1. DG Altman KF Schulz D Moher M Egger F Davidoff D Elbourne, et al. 2001 The revised CONSORT statement for reporting randomized trials: Explanation and elaboration Annals of Internal Medicine 134 663 694 11304107 (Pubitemid 32322245)
2. GP Amminger GE Berger MR Schafer C Klier MH Friedrich M Feucht 2007 Omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study Biological Psychiatry 61 551 553 10.1016/j.biopsych.2006.05.007 16920077 10.1016/j.biopsych.2006.05.007 (Pubitemid 46185334)
3. JG Bell EE MacKinlay JR Dick DJ MacDonald RM Boyle AC Glen 2004 Essential fatty acids and phospholipase A2 in autistic spectrum disorders Prostaglandins, Leukotrienes, and Essential Fatty Acids 71 201 204 10.1016/j.plefa.2004.03.008 15301788 10.1016/j.plefa.2004.03.008 (Pubitemid 39037633)
4. B Bu P Ashwood D Harvey IB King J Van de Water LW Jin 2006 Fatty acid compositions of red blood cell phospholipids in children with autism Prostaglandins, Leukotrienes, and Essential Fatty Acids 74 215 221 10.1016/j.plefa.2006.02.001 16581239 10.1016/j.plefa.2006.02.001
5. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., et al. (1998). Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA, 280, 1569-1575.
6. Eisenberg, D. M., Kessler, R. C., Foster, C., Norlock, F. E., Calkins, D. R., & Delbanco, T. L. (1993). Unconventional medicine in the United States. Prevalence, costs, and patterns of use. New England Journal of Medicine, 328, 246-252.
7. FDA announces qualified health claims for omega-3 fatty acids. (2004). In F. R. P04-89.
8. MP Freeman JR Hibbeln KL Wisner JM Davis D Mischoulon M Peet, et al. 2006 Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry The Journal of Clinical Psychiatry 67 1954 1967 17194275
9. DL Gilbert 2008 Regarding "omega-3 fatty acids supplementation in children with autism: A double-blind randomized, placebo-controlled pilot study" Biological Psychiatry 63 e13 10.1016/j.biopsych.2007.03.028 17555722 10.1016/j.biopsych.2007.03.028 (Pubitemid 350299321)
10. VA Green KA Pituch J Itchon A Choi M O'Reilly J Sigafoos 2006 Internet survey of treatments used by parents of children with autism Research in Developmental Disabilities 27 70 84 10.1016/j.ridd.2004.12.002 15919178 10.1016/j.ridd.2004.12.002 (Pubitemid 41785473)
11. E Hanson LA Kalish E Bunce C Curtis S McDaniel J Ware, et al. 2007 Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder Journal of Autism and Developmental Disorders 37 628 636 10.1007/s10803-006-0192-0 16977497 10.1007/s10803-006-0192-0 (Pubitemid 46571719)
12. JW Harrington L Rosen A Garnecho PA Patrick 2006 Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice Journal of Developmental and Behavioral Pediatrics 27 S156 S161 10.1097/00004703-200604002-00014 16685182 10.1097/00004703-200604002-00014
13. WS Harris 2004 Fish oil supplementation: Evidence for health benefits Cleveland Clinic Journal of Medicine 71 208 221 15055244 10.3949/ccjm.71.3.208
14. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., et al. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 280, 605-613.
15. AR Jadad RA Moore D Carroll C Jenkinson DJ Reynolds DJ Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 17 1 12 10.1016/0197-2456(95)00134-4 8721797 10.1016/0197-2456(95)00134-4 (Pubitemid 26120810)
16. SM Johnson E Hollander 2003 Evidence that eicosapentaenoic acid is effective in treating autism The Journal of Clinical Psychiatry 64 848 849 12934990
17. PM Kris-Etherton WS Harris LJ Appel 2002 Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2747 2757 10.1161/01.CIR.0000038493.65177.94 12438303 10.1161/01.CIR.0000038493.65177.94 (Pubitemid 35364932)
18. SE Levy DS Mandell S Merhar RF Ittenbach JA Pinto-Martin 2003 Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder Journal of Developmental and Behavioral Pediatrics 24 418 423 10.1097/00004703-200312000-00003 14671475 10.1097/00004703-200312000- 00003 (Pubitemid 38035610)
19. Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Stouwe, R. A., Holzman, R. S., et al. (1981). An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. New England Journal of Medicine, 305, 1431-1438.
20. NA Meguid HM Atta AS Gouda RO Khalil 2008 Role of polyunsaturated fatty acids in the management of Egyptian children with autism Clinical Biochemistry 41 1044 1048 10.1016/j.clinbiochem.2008.05.013 18582451 10.1016/j.clinbiochem. 2008.05.013
21. Patrick, L., & Salik, R. (2005). The effect of essential fatty acid supplementation on language development and learning skills in autism and asperger's syndrome. Autism Asperger's Digest, Jan-Feb, pp. 36-37.
22. P Politi H Cena M Comelli G Marrone C Allegri E Emanuele, et al. 2008 Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: An open label study Archives of Medical Research 39 682 685 10.1016/j.arcmed.2008.06.005 18760197 10.1016/j.arcmed.2008.06.005
23. GF Sawaya J Guirguis-Blake M LeFevre R Harris D Petitti 2007 Update on the methods of the US preventive services task force: Estimating certainty and magnitude of net benefit Annals of Internal Medicine 147 871 875 18087058 (Pubitemid 351664424)
24. S Vancassel G Durand C Barthelemy B Lejeune J Martineau D Guilloteau, et al. 2001 Plasma fatty acid levels in autistic children Prostaglandins, Leukotrienes, and Essential Fatty Acids 65 1 7 10.1054/plef.2001.0281 11487301 10.1054/plef.2001.0281 (Pubitemid 32783435)
25. HH Wong RG Smith 2006 Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders Journal of Autism and Developmental Disorders 36 901 909 10.1007/s10803-006-0131-0 16897395 10.1007/s10803-006-0131-0 (Pubitemid 44440109)